Sort by
Refine Your Search
-
Category
-
Field
-
: From Mechanisms to Therapies”. In this CRC we aim to understand how plasticity i.e. non-genetic adaptations of the bone marrow niche induced by the disease or therapeutic agents contribute to drug
-
predisposition to myeloid neoplasms, yet the mechanisms by which they drive disease remain poorly understood. Increasing evidence suggests that both innate immune signaling and alterations in the bone marrow
-
cell sequencing datasets and to combine these data with AI analyses from bone marrow smears. We aim to analyze mechanisms and also to develop new biomarkers for therapy response and resistance. Job-ID
-
center “Cellular Plasticity in Malignant Myeloid Diseases – From Mechanisms to Therapy” and is a close collaboration with the Department of Hematology and other partners in the consortium. Your profile MSc
-
, it is a globally respected institution that also has outstanding economic significance for the Rhine-Neckar metropolitan region. At the Heidelberg Center for Transcultural Studies (HCTS) of Heidelberg
-
PhD position (f/m/d) “How to regulate the duration of mitosis and control cell fate decisions” Centre for Molecular Biology (ZMBH) Heidelberg University, Germany We are seeking highly motivated PhD